PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26477355-7 2015 A multiple logistic regression analysis revealed that nocturia was associated with oxygen desaturation defined as a 3% decrease (P=0.0335) independent of age (P<0.0001), male sex (P=0.0078), hypertension (P=0.0139), and B-type natriuretic peptide (BNP) level (P=0.0185). Oxygen 83-89 natriuretic peptide B Homo sapiens 223-249 26477355-7 2015 A multiple logistic regression analysis revealed that nocturia was associated with oxygen desaturation defined as a 3% decrease (P=0.0335) independent of age (P<0.0001), male sex (P=0.0078), hypertension (P=0.0139), and B-type natriuretic peptide (BNP) level (P=0.0185). Oxygen 83-89 natriuretic peptide B Homo sapiens 251-254 22685026-4 2012 Immediate postoperative BNP correlated with preoperative haematocrit (rho = 0.52, P = 0.03) and inversely with preoperative oxygen saturation (rho = -0.63, P = 0.007). Oxygen 124-130 natriuretic peptide B Homo sapiens 24-27 24521195-1 2014 OBJECTIVES: This study aimed to compare the levels of plasma B-type natriuretic peptide (BNP) and C-reactive protein (CRP) in relation to oxygen transport between patients with restrictive right ventricle (rRV) and those without (non-rRV) early after tetralogy of Fallot (TOF) repair. Oxygen 138-144 natriuretic peptide B Homo sapiens 61-87 24521195-1 2014 OBJECTIVES: This study aimed to compare the levels of plasma B-type natriuretic peptide (BNP) and C-reactive protein (CRP) in relation to oxygen transport between patients with restrictive right ventricle (rRV) and those without (non-rRV) early after tetralogy of Fallot (TOF) repair. Oxygen 138-144 natriuretic peptide B Homo sapiens 89-92 22685026-6 2012 Subsequent BNP expression (post-op day 1) correlated with a low RV fractional area change (rho = -0.51, P = 0.04), high oxygen extraction ratio (rho = 0.56, P = 0.02) and high central venous pressure (rho = 0.79, P < 0.001). Oxygen 120-126 natriuretic peptide B Homo sapiens 11-14 19444132-10 2009 Moreover, in cyanotic defects, BNP showed a significant correlation with O2 saturation (rho=0.204 P=0.0128). Oxygen 73-75 natriuretic peptide B Homo sapiens 31-34 20690091-0 2010 Oxygen uptake efficiency slope correlates with brain natriuretic peptide in patients with heart failure. Oxygen 0-6 natriuretic peptide B Homo sapiens 47-72 17182129-1 2007 BACKGROUND: In patients with chronic heart failure (CHF), B-type natriuretic peptide (BNP) is related to peak oxygen consumption (peak VO2) and the relationship between minute ventilation and carbon dioxide production (VE/VCO2 slope). Oxygen 110-116 natriuretic peptide B Homo sapiens 58-84 19542490-5 2009 To test the hypothesis that reduced oxygen tension can directly stimulate BNP gene expression and release in the absence of hemodynamic or neurohormonal stimuli, we used an in vitro model system of cultured human ventricular myocytes (AC16 cells). Oxygen 36-42 natriuretic peptide B Homo sapiens 74-77 18609042-0 2009 Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients. Oxygen 59-65 natriuretic peptide B Homo sapiens 23-26 17182138-7 2007 Plasma BNP levels correlated positively with indexed RV end-diastolic volume (r=0.6, p=0.009) and pulmonary regurgitant fraction (r=0.54, p=0.026), and negatively with exercise duration (r=-0.45, p=0.021), peak oxygen consumption (r=-0.43, p=0.03), and minute ventilation at maximal exercise (r=-0.52, p=0.006). Oxygen 211-217 natriuretic peptide B Homo sapiens 7-10 17182138-8 2007 Multivariate analysis demonstrated BNP levels (beta=-0.43, p=0.034) and body mass index (beta=-0.40, p=0.036) to be independent predictors of peak oxygen consumption. Oxygen 147-153 natriuretic peptide B Homo sapiens 35-38 19561522-1 2009 PURPOSE: Plasma B-type natriuretic peptide (BNP) levels obtained at rest have been previously shown to be correlated with the global functional capacity measures of peak oxygen uptake (V(O(2peak))) and the minute ventilation/carbon dioxide (VE/V(O(2))) slope. Oxygen 170-176 natriuretic peptide B Homo sapiens 44-47 19254673-6 2009 Resting BNP, DLCO, and DM correlate with peak oxygen consumption (P < .0001 for all analyses). Oxygen 46-52 natriuretic peptide B Homo sapiens 8-11 18563310-6 2008 Measurement of exercise-induced BNP levels may be a useful alternative to pulmonary artery catheterisation in identifying the patients who are likely to benefit from long-term oxygen therapy. Oxygen 176-182 natriuretic peptide B Homo sapiens 32-35 17934262-6 2008 Plasma BNP was weakly, negatively correlated to maximum exercise capability, peak oxygen uptake, maximum heart rate during exercise testing and minimal heart rate in the 24-hour Holter monitoring. Oxygen 82-88 natriuretic peptide B Homo sapiens 7-10 17182129-1 2007 BACKGROUND: In patients with chronic heart failure (CHF), B-type natriuretic peptide (BNP) is related to peak oxygen consumption (peak VO2) and the relationship between minute ventilation and carbon dioxide production (VE/VCO2 slope). Oxygen 110-116 natriuretic peptide B Homo sapiens 86-89 16806535-10 2007 Oxygen therapy significantly decreased AHI and 4 serum BNP levels (from 91.75+/-80.35 pg/ml to 52.75+/-45.70 pg/ml, mean change=33.85 pg/ml, P=0.0208). Oxygen 0-6 natriuretic peptide B Homo sapiens 55-58 17449423-7 2007 RESULTS: Plasma levels of NT Pro BNP correlated significantly with peak oxygen consumption (VO(2)) values (r = -0.77, p < 0.001). Oxygen 72-78 natriuretic peptide B Homo sapiens 33-36 17478157-11 2007 Patients with BNP release (vs patients without) had higher maximum oxygen consumption (19.2 +/- 5.1 vs 15.9 +/- 3.6, p <0.001), better functional capacity (59 +/- 13% vs 50 +/- 15%, p = 0.002), and lower minute ventilation/carbon dioxide production slope (33.6 +/- 4.8 vs 36.5 +/- 7.7, p = 0.026) independent of other clinical parameters. Oxygen 67-73 natriuretic peptide B Homo sapiens 14-17 16893708-11 2006 In conclusion, NT-pro-BNP levels correlate with peak oxygen consumption in HC and are more predictive of functional impairment than other conventional markers of disease severity. Oxygen 53-59 natriuretic peptide B Homo sapiens 22-25 17225483-0 2007 B-type natriuretic peptide in healthy subjects after exposure to hyperbaric oxygen at 2.5 ATA. Oxygen 76-82 natriuretic peptide B Homo sapiens 0-26 16039193-1 2005 BACKGROUND: Nesiritide is a recombinant brain-type natriuretic peptide (BNP), which decreases pulmonary arterial (PA) pressures and myocardial oxygen consumption while increasing coronary flow and urine output. Oxygen 143-149 natriuretic peptide B Homo sapiens 40-70 16112902-5 2006 BNP and NT-proBNP levels correlated with peak oxygen consumption (VO2) (both R = -0.53, p < 0.001), VE/VCO2 slope (R = 0.56; p < 0.001 and R = 0.58; p < 0.001, respectively) and maximum workload (R = -0.49; p < 0.001 and R = -0.47; p < 0.001, respectively). Oxygen 46-52 natriuretic peptide B Homo sapiens 0-3 16222887-7 2005 BNP levels correlated with PAP (r = 0.68), partial arterial oxygen pressure (r = -0.70), FEV1 (r = -0.65) and FVC (r = -0.52). Oxygen 60-66 natriuretic peptide B Homo sapiens 0-3 16039193-1 2005 BACKGROUND: Nesiritide is a recombinant brain-type natriuretic peptide (BNP), which decreases pulmonary arterial (PA) pressures and myocardial oxygen consumption while increasing coronary flow and urine output. Oxygen 143-149 natriuretic peptide B Homo sapiens 72-75 15576492-6 2004 In support of a hypoxia-induced increase of BNP gene transcription, the content of a premature BNP mRNA was increased in hypoxic myocardium (4.8-fold, P<0.005) and in freshly harvested ventricular myocytes when kept in culture flasks and oxygen-deprived for 3 h (2.2-fold, P=0.002). Oxygen 241-247 natriuretic peptide B Homo sapiens 44-47 16177675-1 2005 AIM: Aim of the study was to evaluate if brain natriuretic peptide (BNP) levels, a cardiac neurohormone well correlated with prognosis in chronic heart failure (CHF), are associated with enhanced ventilatory response to exercise, in ambulatory patients with intermediate peak oxygen uptake (PVO2). Oxygen 276-282 natriuretic peptide B Homo sapiens 41-66 16177675-1 2005 AIM: Aim of the study was to evaluate if brain natriuretic peptide (BNP) levels, a cardiac neurohormone well correlated with prognosis in chronic heart failure (CHF), are associated with enhanced ventilatory response to exercise, in ambulatory patients with intermediate peak oxygen uptake (PVO2). Oxygen 276-282 natriuretic peptide B Homo sapiens 68-71 15576492-6 2004 In support of a hypoxia-induced increase of BNP gene transcription, the content of a premature BNP mRNA was increased in hypoxic myocardium (4.8-fold, P<0.005) and in freshly harvested ventricular myocytes when kept in culture flasks and oxygen-deprived for 3 h (2.2-fold, P=0.002). Oxygen 241-247 natriuretic peptide B Homo sapiens 95-98 12970147-7 2003 Moreover, in multiple regression analysis, proBNP and BNP were also related to arterial carbon dioxide and oxygen tensions. Oxygen 107-113 natriuretic peptide B Homo sapiens 46-49 12352313-5 2002 In multiple regression analyses, the major determinants of peak oxygen uptake (VO max) were age (-), sex (male), peak exercise systolic BP (+) and post-exercise BNP (-). Oxygen 64-70 natriuretic peptide B Homo sapiens 161-164 8865684-5 1996 Plasma BNP in the first month had a significant negative correlation with anaerobic threshold (AT) and peak oxygen uptake (peak VO2), and the serial change in plasma BNP from the first to third month had a significant negative correlation with the serial change of AT (peak: r = -0.35, p < 0.05) and peak VO2 (rest: r = -0.35, p < 0.05; peak: r = -0.45, p < 0.01). Oxygen 108-114 natriuretic peptide B Homo sapiens 7-10 12204502-6 2002 RESULTS: In patients with chronic HF, BNP levels correlated with oxygen uptake (VO(2)), both at anaerobic threshold (VO(2)AT: r = -0.54, p < 0.001) and peak exercise (peak VO(2): r = -0.56, p < 0.001). Oxygen 65-71 natriuretic peptide B Homo sapiens 38-41 11670819-19 1998 The BNP(-) group bridges the pair of metal ions through its two oxygens, together with two phenolic oxygens of (L)(2)(-). Oxygen 64-71 natriuretic peptide B Homo sapiens 4-7 11670819-19 1998 The BNP(-) group bridges the pair of metal ions through its two oxygens, together with two phenolic oxygens of (L)(2)(-). Oxygen 100-107 natriuretic peptide B Homo sapiens 4-7 34855654-10 2022 Concurrently, BNP at discharge was correlated with age, central DBP (cDBP), urea, creatinine, LVEDD, partial oxygen pressure (pO2), and oxygen saturation (SO2). Oxygen 109-115 natriuretic peptide B Homo sapiens 14-17 34855654-10 2022 Concurrently, BNP at discharge was correlated with age, central DBP (cDBP), urea, creatinine, LVEDD, partial oxygen pressure (pO2), and oxygen saturation (SO2). Oxygen 136-142 natriuretic peptide B Homo sapiens 14-17 33746081-12 2021 Patient"s characteristics that were associated with confirmed HF and high BNP levels were the following: presence of fatigue, night cough, elevated heart rate, shortness of breath, history of lung fibrosis and decreased oxygen arterial saturation (p < 0.05) Pulmonary hypertension, mitral and tricuspid regurgitation, and cor pulmonale were also associated with higher BNP levels. Oxygen 220-226 natriuretic peptide B Homo sapiens 74-77 28704502-0 2017 Brain natriuretic peptide (BNP) may play a major role in risk stratification based on cerebral oxygen saturation by near-infrared spectroscopy in patients undergoing major cardiovascular surgery. Oxygen 95-101 natriuretic peptide B Homo sapiens 27-30 27753705-8 2016 Results of multinomial logistic regression analysis indicated that BNP level was a significant determinant for the riser pattern [odds ratio (OR) 1.27 (BNP 10 pg/ml), P < 0.001], whereas oxygen desaturation was specifically associated with the nondipping pattern (OR 1.04, P = 0.001). Oxygen 190-196 natriuretic peptide B Homo sapiens 67-70 32597024-3 2020 The effects of B-type natriuretic peptide (BNP) in suppressing superoxide (O2 - ) release from neutrophils are transiently impaired in acute heart failure. Oxygen 75-79 natriuretic peptide B Homo sapiens 15-41 32597024-3 2020 The effects of B-type natriuretic peptide (BNP) in suppressing superoxide (O2 - ) release from neutrophils are transiently impaired in acute heart failure. Oxygen 75-79 natriuretic peptide B Homo sapiens 43-46 32597024-4 2020 We also evaluated the extent and duration of BNP-induced suppression of O2 - release post-TTS. Oxygen 72-74 natriuretic peptide B Homo sapiens 45-48 32597024-8 2020 Relative to control subjects, in TTS patients, BNP suppression of both phorbol myristate acetate and N-formyl-methionyl-leucyl-phenylalanine-induced O2 - release was impaired acutely (P < 0.05 for both); this did not improve over the 3-month recovery period, despite treatment with conventional anti-failure medication in 85% of patients. Oxygen 149-151 natriuretic peptide B Homo sapiens 47-50 32597024-10 2020 CONCLUSIONS: (1) While TTS is associated with marked and prolonged release of BNP, there is virtually total loss of the ability of BNP to suppress neutrophil O2 - release and its impact on tissue inflammation. Oxygen 158-162 natriuretic peptide B Homo sapiens 131-134 28969979-1 2018 BACKGROUND: B-type natriuretic peptide (BNP) has been found to be inversely related to peak oxygen consumption (peak VO2) in various patient populations. Oxygen 92-98 natriuretic peptide B Homo sapiens 12-38 28969979-1 2018 BACKGROUND: B-type natriuretic peptide (BNP) has been found to be inversely related to peak oxygen consumption (peak VO2) in various patient populations. Oxygen 92-98 natriuretic peptide B Homo sapiens 40-43 28778770-0 2018 B-Type Natriuretic Peptide and Hemoglobin are Two Major Factors Significantly Associated With Baseline Cerebral Oxygen Saturation Measured Using the INVOS Oximeter in Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery. Oxygen 112-118 natriuretic peptide B Homo sapiens 0-26 27581116-8 2016 Increased serum BNP levels were significantly associated with mean transcutaneous oxygen saturation (SpO2) (p<0.0001), minimal SpO2 (p=0.002), oxygen desaturation index (p=0.001), and total sleep time spent with SpO2 lower than 90% (p=0.002). Oxygen 82-88 natriuretic peptide B Homo sapiens 16-19